Tailored tumor tests aim to extend brain cancer survival
NCT ID NCT06512311
First seen Apr 24, 2026 · Last updated May 24, 2026 · Updated 10 times
Summary
This study tests whether using a patient's own tumor cells to screen drugs can lead to more effective, personalized treatment for glioblastoma, a severe brain cancer. About 240 adults with newly diagnosed glioblastoma will either receive standard care or standard care plus a personalized drug plan based on lab tests. The goal is to see if this approach improves overall survival and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AKH Vienna, Department for Internal Medicine I, Oncology
RECRUITINGVienna, State of Vienna, 1090, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.